Cancer-Derived Exosomes: A Cross-Cancer Comparative Analysis of Exosomal Proteins and MicroRNAs

Area of Science:

• Oncology
• Molecular Biology
• Biochemistry

Background:

• Exosomes are key mediators of intercellular communication, transporting molecules that reflect tumor status and influence the tumor microenvironment.
• While exosomal proteins and microRNAs are studied individually in various cancers, comprehensive comparative analyses are rare.
• Understanding the shared and distinct molecular cargo across different cancer types is crucial for advancing cancer research.

Purpose of the Study:

• To compile and re-analyze previously reported exosomal proteins and microRNAs from eight major cancer categories within a unified functional framework.
• To compare exosomal molecular profiles across hematologic and solid malignancies to identify common and cancer-specific signaling pathways.
• To explore the potential of integrated protein and microRNA profiling for refining cancer classification and biomarker discovery.

Main Methods:

• Systematic compilation of exosomal proteins and microRNA-target pairs from curated repositories across blood, breast, colon, kidney, liver, lung, prostate, and stomach cancers.
• Functional annotation and organization of compiled data using Gene Ontology, KEGG, and PANTHER databases.
• Comparative analysis of protein and microRNA functions, localizations, and pathways between hematologic and solid tumors.

Main Results:

• Analysis encompassed 3643 exosomal proteins and 627,225 miRNA-target pairs from 350 unique microRNAs.
• Exosomal proteins across cancers converged on core functions including signaling, transport, and cytoskeletal organization, primarily involving binding and catalytic activities.
• Comparisons revealed shared cancer-associated functions alongside context-dependent patterns related to tissue origin and disease ecology, highlighting differences between hematologic and solid tumors.

Conclusions:

• Integrated exosomal protein and microRNA profiling provides a robust framework for understanding cancer cell communication.
• This approach can refine cancer classification and advance the discovery of novel diagnostic and prognostic biomarkers.
• Harmonized analytical workflows, independent validation, and mechanistic studies are essential for translating these findings into clinical applications.